Aliases & Classifications for Stomatitis

MalaCards integrated aliases for Stomatitis:

Name: Stomatitis 12 77 56 45 15 17 74

Classifications:



External Ids:

Disease Ontology 12 DOID:9637
MeSH 45 D013280
NCIt 51 C26887
SNOMED-CT 69 61170000 95361005
ICD10 34 K12.1
UMLS 74 C0038362

Summaries for Stomatitis

MalaCards based summary : Stomatitis is related to influenza and measles, and has symptoms including enanthema, oral mucosal blisters and oral manifestations. An important gene associated with Stomatitis is LDLR (Low Density Lipoprotein Receptor), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Miconazole and Nystatin have been mentioned in the context of this disorder. Affiliated tissues include t cells, bone and breast, and related phenotype is immune system.

Wikipedia : 77 Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the... more...

Related Diseases for Stomatitis

Diseases related to Stomatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 267)
# Related Disease Score Top Affiliating Genes
1 influenza 30.6 DDX58 EIF2AK2 IFITM2 IFITM3 RSAD2
2 measles 30.5 ADAR DDX58 EIF2AK2
3 chikungunya 30.3 BST2 DDX58 RSAD2
4 hepatitis c 30.3 DDX58 EIF2AK2 IFNA2 LDLR
5 ebola hemorrhagic fever 29.9 BST2 DDX58
6 hepatitis c virus 29.9 ATG5 BST2 DDX58 EIF2AK2 HNRNPK LDLR
7 west nile virus 29.7 DDX58 IFITM2 IFITM3 RSAD2
8 neutropenia 28.9 CSF2 CSF3 IFNA2
9 aphthous stomatitis 12.6
10 periodic fever, aphthous stomatitis, pharyngitis and adenitis 12.5
11 denture stomatitis 12.5
12 ulcerative stomatitis 12.4
13 sutton disease 2 12.1
14 noma 11.6
15 hand, foot and mouth disease 11.6
16 ariboflavinosis 11.4
17 angular cheilitis 11.4
18 necrotizing ulcerative gingivitis 11.4
19 glucagonoma 11.4
20 methylmalonic aciduria and homocystinuria, cblf type 11.1
21 pharyngitis 10.7
22 oral candidiasis 10.6
23 cervical adenitis 10.5
24 herpes simplex 10.3
25 gingivitis 10.3
26 leukemia 10.3
27 hepatitis 10.2
28 vaccinia 10.2
29 dermatitis 10.2
30 lichen planus 10.2
31 newcastle disease 10.2
32 encephalitis 10.2
33 human immunodeficiency virus type 1 10.2
34 mouth disease 10.2
35 breast cancer 10.2
36 oral lichen planus 10.2
37 dengue virus 10.2 DDX58 IFITM2 IFITM3 RSAD2
38 glossitis 10.1
39 anxiety 10.1
40 mucositis 10.1
41 celiac disease 1 10.1
42 rabies 10.1
43 uvulitis 10.1
44 exanthem 10.1
45 viral infectious disease 10.0 DDX58 EIF2AK2 IFNA2
46 polycythemia vera 10.0
47 lymphoma 10.0
48 cheilitis 10.0
49 severe acute respiratory syndrome 10.0
50 adenocarcinoma 10.0

Graphical network of the top 20 diseases related to Stomatitis:



Diseases related to Stomatitis

Symptoms & Phenotypes for Stomatitis

UMLS symptoms related to Stomatitis:


enanthema, oral mucosal blisters, oral manifestations, burning mucosal, oral pain, sore roof of mouth (symptom)

MGI Mouse Phenotypes related to Stomatitis:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.36 ADAR ATG5 CSF2 CSF3 DDX58 EIF2AK2

Drugs & Therapeutics for Stomatitis

Drugs for Stomatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 450)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
2
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1400-61-9 11953884
3
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 57-27-2 5288826
4
Docetaxel Approved, Investigational Phase 4,Phase 3,Phase 2 114977-28-5 148124
5
Sargramostim Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 123774-72-1, 83869-56-1
6
leucovorin Approved Phase 4,Phase 2,Phase 3,Phase 1 58-05-9 6006 143
7
Povidone Approved Phase 4,Phase 2,Not Applicable 9003-39-8
8
Methotrexate Approved Phase 4,Phase 2,Phase 3 1959-05-2, 59-05-2 126941
9
Hyaluronic acid Approved, Vet_approved Phase 4,Not Applicable 9004-61-9 53477741
10
Racepinephrine Approved Phase 4,Phase 1 329-65-7 838
11
Epinephrine Approved, Vet_approved Phase 4,Phase 1 51-43-4 5816
12
Melphalan Approved Phase 4,Phase 3,Phase 2,Not Applicable 148-82-3 460612 4053
13
Methylene blue Approved, Investigational Phase 4,Phase 3,Early Phase 1 61-73-4
14
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 55-56-1 2713 9552079
15
Sodium Citrate Approved, Investigational Phase 4,Phase 3 68-04-2
16
Hexetidine Approved, Investigational Phase 4 141-94-6
17
Ethanol Approved Phase 4,Phase 2,Phase 1 64-17-5 702
18
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2 135968-09-1
19
Pemetrexed Approved, Investigational Phase 4,Phase 3 150399-23-8, 137281-23-3 60843 446556
20
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Early Phase 1 7440-66-6 32051
21
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 53123-88-9 46835353 6436030 5284616
22
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492 6473866
23
Everolimus Approved Phase 4,Phase 3,Phase 2,Not Applicable 159351-69-6 6442177 70789204
24
Infliximab Approved Phase 4,Phase 2,Phase 1 170277-31-3
25
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 137-58-6 3676
26
Diphenhydramine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 147-24-0, 58-73-1 3100
27
Magnesium hydroxide Approved, Investigational Phase 4,Phase 2,Phase 3 1309-42-8
28
Promethazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 60-87-7 4927
29
Aluminum hydroxide Approved, Investigational Phase 4,Phase 2,Phase 3 21645-51-2
30
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 51-45-6 774
31
afatinib Approved Phase 4,Phase 2,Phase 1 850140-72-6, 439081-18-2 10184653
32
Simethicone Approved Phase 4 8050-81-5
33
Deferasirox Approved, Investigational Phase 4 201530-41-8 5493381
34
Iron Approved, Experimental Phase 4 7439-89-6, 15438-31-0 23925 27284
35
Amifostine Approved, Investigational Phase 4,Phase 2 20537-88-6 2141
36
Calcium Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 7440-70-2 271
37
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 59-30-3 6037
38
Castor oil Approved, Investigational, Nutraceutical, Vet_approved Phase 4 8001-79-4
39
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3 77-92-9 311
40
Vitamin C Approved, Nutraceutical Phase 4,Phase 2,Phase 3 50-81-7 5785 54670067
41 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
42 Ionophores Phase 4,Phase 3,Phase 2
43 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
45 Calcium, Dietary Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
46 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
47 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
48 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
49 Narcotics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
50 Analgesics, Opioid Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 432)
# Name Status NCT ID Phase Drugs
1 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Unknown status NCT01876407 Phase 4
2 Oral Hygiene Regimen in Patients on HCT Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
3 A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients Completed NCT01283906 Phase 4
4 Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy Completed NCT00357942 Phase 4 morphine solution for injection;Placebo;morphine mouthwash;Placebo
5 Effectiveness of Hygiene Solutions on Denture Biofilm Completed NCT02407834 Phase 4
6 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4 Kepivance (Palifermin)
7 Photodynamic Therapy Against Candida Spp. in Complete Denture Wearers Completed NCT02642900 Phase 4 Nystatin 100.000 units
8 Hexetidine and Chlorobutanol for Lesions Due to Prostheses Completed NCT01115049 Phase 4 chlorobutanol, hexetidine;Chlorhexidine
9 A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen Completed NCT01107756 Phase 4 LENOGRASTIM (GRANOGYTE 34)
10 Chemotherapy for Patients With Non-Small Cell Lung Cancer Completed NCT00380718 Phase 4 pemetrexed
11 Oral Zinc Therapy for the Prevention of Mucositis Completed NCT00449592 Phase 4 Zinc;Placebo
12 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) Completed NCT02256553 Phase 4 Rescue Medication
13 Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Completed NCT00895583 Phase 4 Tacrolimus;Sirolimus;Tacrolimus
14 Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery Completed NCT00688636 Phase 4 infliximab;placebo
15 Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye Completed NCT01488396 Phase 4 0.05%cyclosporin eye drop
16 Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients Recruiting NCT03490396 Phase 4
17 Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer Recruiting NCT01707641 Phase 4
18 Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis Recruiting NCT03372083 Phase 4 Deferasirox
19 G-CSF in the Treatment of Toxic Epidermal Necrolysis Recruiting NCT02739295 Phase 4 recombinant granulocyte - colony stimulating factor;NaCl 0.9%
20 A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients Active, not recruiting NCT02948699 Phase 4
21 Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older Active, not recruiting NCT02514174 Phase 4 Afatinib
22 Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine Suspended NCT01288625 Phase 4 Amifostine
23 Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) Terminated NCT02695290 Phase 4 Afatinib
24 The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients Unknown status NCT01099891 Phase 3 rhEGF;Placebo
25 Low-energy Laser Therapy for Prevention of Oral Mucositis in Children Unknown status NCT01007617 Phase 2, Phase 3
26 Lactobacillus Brevis CD2 Preventing Oral Mucositis Unknown status NCT02085694 Phase 2, Phase 3 Lactobacillus brevis CD2
27 Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation Unknown status NCT02313792 Phase 3 Palifermin
28 Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer Unknown status NCT00022373 Phase 3 iseganan HCl oral solution
29 Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? Unknown status NCT02020928 Phase 3
30 Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation Unknown status NCT02282839 Phase 3
31 Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults Unknown status NCT02173756 Phase 3 morphine gel;placebo gel
32 The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome Unknown status NCT02506231 Phase 2, Phase 3 Folinic acid;Placebo
33 The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus Unknown status NCT01083420 Phase 3 Minocycline;Dexamethasone
34 Traumeel for Post-Tonsillectomy Pain Unknown status NCT00410332 Phase 3 Traumeel S;Placebo
35 COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma Unknown status NCT00603759 Phase 3 celecoxib;placebo
36 Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation Unknown status NCT01615757 Phase 3 Ara-c;Ara-c
37 Laser for Oral Mucositis in Pediatric Onco-hematology Completed NCT02762019 Phase 3
38 Prevention of Recurrent Aphthous Stomatitis Using Vitamins Completed NCT00527306 Phase 3
39 Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers Completed NCT02868151 Phase 2, Phase 3 Ascorbic Acid;Zinc acetate
40 Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients Completed NCT01439724 Phase 3
41 Low-level Laser Therapy on Inflammatory Mediators During Chemotherapy-induced Oral Mucositis Completed NCT02050373 Phase 3
42 Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis Completed NCT02303197 Phase 3 ChiNing decoction
43 Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy Completed NCT02555501 Phase 3
44 Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx Completed NCT00051441 Phase 3 Benzydamine Hydrochloride 0.15% Oral Rinse
45 Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Completed NCT00101582 Phase 3 Placebo;palifermin;cisplatin chemotherapy
46 Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy Completed NCT02229539 Phase 3 doxepin hydrochloride oral solution;DLA (diphenhydramine, lidocaine and antacids) rinse
47 Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer Completed NCT01837446 Phase 2, Phase 3 2% morphine solution;Magnesium aluminum hydroxide;2% viscous lidocaine;Diphenhydramine
48 Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) Completed NCT00109031 Phase 3 palifermin;Cyclophosphamide;Etoposide;Placebo
49 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer Completed NCT00393822 Phase 2, Phase 3 palifermin;placebo
50 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Completed NCT00131638 Phase 3 Placebo;Palifermin

Search NIH Clinical Center for Stomatitis

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: stomatitis

Genetic Tests for Stomatitis

Anatomical Context for Stomatitis

MalaCards organs/tissues related to Stomatitis:

42
T Cells, Bone, Breast, Bone Marrow, Eye, Kidney, Testes

Publications for Stomatitis

Articles related to Stomatitis:

(show top 50) (show all 3257)
# Title Authors Year
1
Patients who seek professional treatment of recurrent aphthous stomatitis probably have an increased risk of having head and neck cancer and other types of cancers. ( 30340756 )
2019
2
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review. ( 30488366 )
2019
3
Serum levels of total antioxidant status, nitric oxide and nitric oxide synthase in minor recurrent aphthous stomatitis patients. ( 30653111 )
2019
4
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome - PFAPA syndrome. ( 30683466 )
2019
5
Design, Development and In vitro/Ex vivo Evaluation of Mucoadhesive Buccal Film of Benzydamine Hydrochloride for the Effective Treatment of Aphthous Stomatitis. ( 30706830 )
2019
6
Immunogenicity and side-effects of the inactivated hepatitis A vaccine in periodic fever, aphthous stomatitis, pharyngitis, and adenitis patients. ( 30734430 )
2019
7
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: main features and an algorithm for clinical practice. ( 30798384 )
2019
8
Azithromycin-induced aphthous stomatitis: a case series. ( 30827258 )
2019
9
Effect of Sodium Lauryl Sulfate on Recurrent Aphthous Stomatitis: A Systematic Review. ( 30839136 )
2019
10
Mediterranean fever gene variants and colchicine therapy in periodic fever, aphthous stomatitis pharyngitis, adenitis syndrome in a Mediterranean region. ( 30887853 )
2019
11
Towards better diagnostic criteria for PFAPA (periodic fever, aphthous stomatitis, pharyngitis and adenitis) syndrome. ( 30901126 )
2019
12
Diagnostic Value of Neutrophil-Lymphocyte Ratios and Mean Platelet Volumes in the Activation of Recurrent Aphthous Stomatitis. ( 30906727 )
2019
13
In-vitro antifungal efficacy of tissue conditioner-chitosan composites as potential treatment therapy for denture stomatitis. ( 30543887 )
2019
14
Effectiveness of an Alcohol-Free Chitosan-Curcuminoid Mouthwash Compared with Chlorhexidine Mouthwash in Denture Stomatitis Treatment: A Randomized Trial. ( 30758216 )
2019
15
A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs. ( 30774999 )
2019
16
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans. ( 30452666 )
2019
17
Optimization of production of vesicular stomatitis virus (VSV) in suspension serum-free culture medium at high cell density. ( 30508556 )
2019
18
Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors. ( 30622188 )
2019
19
Defining of MAbs-neutralizing sites on the surface glycoproteins Gn and Gc of a hantavirus using vesicular stomatitis virus pseudotypes and site-directed mutagenesis. ( 30624178 )
2019
20
Validation of a site-specific recombination cloning technique for the rapid development of a full-length cDNA clone of a virulent field strain of vesicular stomatitis New Jersey virus. ( 30639413 )
2019
21
Sequential detection of pseudocowpox virus and bovine papular stomatitis virus in a same calf in Japan. ( 30674740 )
2019
22
Search for Drugs Used in Hospitals to Treat Stomatitis. ( 30699927 )
2019
23
Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector. ( 30769947 )
2019
24
A Vesicular Stomatitis Virus-Based Vaccine Carrying Zika Virus Capsid Protein Protects Mice from Viral Infection. ( 30820837 )
2019
25
Image Gallery: Recurrent bovine papular stomatitis virus infection diagnosed by nested polymerase chain reaction. ( 30821380 )
2019
26
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study. ( 30833486 )
2019
27
Novel near-infrared fluorescence-guided surgery with vesicular stomatitis virus for complete surgical resection of osteosarcomas in mice. ( 30839125 )
2019
28
Coinfection of a lingual lesion with bovine papular stomatitis virus and bovine papillomavirus. ( 30847608 )
2019
29
Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine. ( 30878249 )
2019
30
Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breastA cancer. ( 29439772 )
2018
31
Association of Serotonin Transporter Gene Polymorphism with Recurrent Aphthous Stomatitis. ( 29296268 )
2018
32
Fulminant presentation of oral mucosal leishmaniasis as severe stomatitis and periodontitis. ( 29380732 )
2018
33
Tonsillar antimicrobial peptide (AMP) expression profiles of periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) patients. ( 29859567 )
2018
34
Characterization of Herbal Antifungal Agent, <i>Origanum vulgare</i> against Oral <i>Candida</i> spp. Isolated from Patients with <i>Candida</i>-Associated Denture Stomatitis: An <i>In vitro</i> Study. ( 29962756 )
2018
35
Prevalence and psychological stress in recurrent aphthous stomatitis among female dental students in Saudi Arabia. ( 29785161 )
2018
36
Allergic contact stomatitis caused by propolis candies. ( 29411380 )
2018
37
The association between minor recurrent aphthous stomatitis (RAS), children's poor oral condition, and underlying negativeA psychosocial habits and attitudes towards oral hygiene. ( 29653566 )
2018
38
Comorbidity of PFAPA (periodic fever, aphthous stomatitis, pharyngitis and adenitis) patients: a case control study. ( 29533751 )
2018
39
Role of laser or photodynamic therapy in treatment of denture stomatitis: A systematic review. ( 29807743 )
2018
40
An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA). ( 29669569 )
2018
41
Severe Airflow Obstruction in a Man with Stomatitis and Lymphadenopathy. ( 29286849 )
2018
42
Vesicular stomatitis forecasting based on Google Trends. ( 29385198 )
2018
43
Gastric parietal cell and thyroid autoantibodies in recurrent aphthous stomatitis patients with concomitant oral lichen planus. ( 29753458 )
2018
44
Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigs. ( 29869979 )
2018
45
Identification of bacteria present in ulcerative stomatitis lesions of captive sea turtles Chelonia mydas. ( 29934703 )
2018
46
Autosomal dominant deficiency of the interleukin-17F in recurrent aphthous stomatitis: Possible novel mutation in a new entity. ( 29458167 )
2018
47
Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor. ( 29212930 )
2018
48
Management of denture stomatitis: a narrative review. ( 29460527 )
2018
49
Cytokine gene polymorphism in denture stomatitis patients: A clinical study. ( 29423993 )
2018
50
Mycoplasma pneumoniae-associated mucositis with severe blistering stomatitis and pneumonia successfully treated with azithromycin and infusion therapy. ( 29952018 )
2018

Variations for Stomatitis

Expression for Stomatitis

Search GEO for disease gene expression data for Stomatitis.

Pathways for Stomatitis

Pathways related to Stomatitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.73 ADAR ATG12 ATG5 BST2 CSF2 CSF3
2
Show member pathways
12.88 ADAR BST2 CSF2 CSF3 DDX58 EIF2AK2
3
Show member pathways
12.55 ADAR ATG12 ATG5 DDX58 IFNA2 UBA52
4
Show member pathways
12.39 ADAR DDX58 EIF2AK2 HNRNPK IFNA2 NUP98
5
Show member pathways
12.08 ADAR BST2 IFI35 IFITM2 IFITM3 IFNA2
6
Show member pathways
11.85 ADAR BST2 DDX58 EIF2AK2 IFI35 IFITM2
7 11.7 CSF2 CSF3 IFNA2
8
Show member pathways
11.27 ATG12 ATG5 UBA52
9
Show member pathways
10.82 ADAR DDX58 EIF2AK2 IFNA2

GO Terms for Stomatitis

Cellular components related to Stomatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 phagophore assembly site membrane GO:0034045 8.96 ATG12 ATG5
2 Atg12-Atg5-Atg16 complex GO:0034274 8.62 ATG12 ATG5

Biological processes related to Stomatitis according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 9.95 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
2 immune system process GO:0002376 9.93 ADAR ATG5 DDX58 EIF2AK2 RSAD2
3 viral process GO:0016032 9.93 DDX58 EIF2AK2 HNRNPK LDLR NUP98 RSAD2
4 negative regulation of apoptotic process GO:0043066 9.92 ADAR ATG5 EIF2AK2 HNRNPK UBA52
5 cytokine-mediated signaling pathway GO:0019221 9.81 CSF2 CSF3 IFNA2 UBA52
6 response to virus GO:0009615 9.8 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
7 defense response to virus GO:0051607 9.76 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
8 negative regulation of viral genome replication GO:0045071 9.72 BST2 EIF2AK2 IFITM2 IFITM3 RSAD2
9 response to interferon-gamma GO:0034341 9.65 BST2 IFITM2 IFITM3
10 negative regulation of viral entry into host cell GO:0046597 9.61 IFITM2 IFITM3 IFNA2
11 response to interferon-beta GO:0035456 9.54 BST2 IFITM2 IFITM3
12 C-terminal protein lipidation GO:0006501 9.49 ATG12 ATG5
13 response to interferon-alpha GO:0035455 9.35 ADAR BST2 EIF2AK2 IFITM2 IFITM3
14 type I interferon signaling pathway GO:0060337 9.17 ADAR BST2 IFI35 IFITM2 IFITM3 IFNA2

Molecular functions related to Stomatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.89 ADAR AHSA1 ATG12 ATG5 BST2 CSF2
2 identical protein binding GO:0042802 9.73 BST2 DDX58 EIF2AK2 HNRNPK LDLR TP63
3 double-stranded RNA binding GO:0003725 9.33 ADAR DDX58 EIF2AK2
4 Atg8 ligase activity GO:0019776 8.62 ATG12 ATG5

Sources for Stomatitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....